title: Antiphospholipid syndrome development after rituximab treatment.
authors.forename: César
authors.initials: C
authors.lastname: Faillace
authors.forename: Jozélio Freire
authors.initials: JF
authors.lastname: de Carvalho
mesh_terms: D000328:Adult; D058846:Antibodies, Monoclonal, Murine-Derived / Q000009:adverse effects* / Q000627:therapeutic use; D016736:Antiphospholipid Syndrome / Q000139:chemically induced* / Q000175:diagnosis*; D018501:Antirheumatic Agents / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D012307:Risk Factors; D000069283:Rituximab; D013927:Thrombosis / Q000139:chemically induced / Q000453:epidemiology
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents; D000069283:Rituximab